Singapore markets closed

BioCryst Pharmaceuticals, Inc. (BCRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.34-0.05 (-0.60%)
At close: 04:00PM EDT
8.43 +0.09 (+1.08%)
After hours: 07:35PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts11111212
Avg. Estimate-0.3-0.26-1.01-0.57
Low estimate-0.39-0.31-1.19-1.27
High estimate-0.16-0.2-0.8-0.14
Year ago EPS-0.4-0.32-1.33-1.01
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts10101111
Avg. Estimate71.47M79.77M327.17M408.68M
Low estimate68.5M75.97M318.53M358M
High estimate78.63M84.7M333.56M435.4M
Year ago sales49.92M65.53M270.83M327.17M
Sales growth (year/est)43.20%21.70%20.80%24.90%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.37-0.34-0.29-0.17
Actual EPS-0.4-0.32-0.23-0.38
Difference-0.030.020.06-0.21
Surprise %-8.10%5.90%20.70%-123.50%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate-0.3-0.26-1.01-0.57
7 days ago-0.3-0.26-1.01-0.57
30 days ago-0.3-0.26-0.99-0.51
60 days ago-0.24-0.22-0.87-0.32
90 days ago-0.27-0.24-0.79-0.26
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBCRXIndustrySector(s)S&P 500
Current qtr.25.00%N/AN/AN/A
Next qtr.18.80%N/AN/AN/A
Current year24.10%N/AN/AN/A
Next year43.60%N/AN/AN/A
Next 5 years (per annum)44.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A